Research News

A national study led by Jacobs School of Medicine and Biomedical Sciences emergency medicine physicians has found that patients with mild to moderate COVID-19 who are treated with an inhaled steroid are significantly less likely to require emergency department care or hospitalization due to COVID-19 than those treated with placebo.

Darshana Govind, PhD, extols the virtues of researching artificial intelligence. She’s so enthusiastic about it, she wants to encourage more women to enter the field.

The American Society for Pharmacology and Experimental Therapeutics (ASPET) has announced that Margarita L. Dubocovich, PhD, SUNY Distinguished Professor of pharmacology and toxicology, is the recipient of the 2022 Julius Axelrod Award in Pharmacology.

A type of acupressure focused on pressure points in the ear could be a promising treatment for functional abdominal pain disorder (FAPD), a challenging group of disorders that cause chronic abdominal pain in 13.5 percent of children and adolescents.

Kateryna Murlanova, PhD, a postdoctoral associate in the Department of Physiology and Biophysics, has received a 2021 Trainee Professional Development Award (TPDA) from the Society for Neuroscience (SfN).

To more powerfully address and reverse Buffalo’s entrenched health disparities, a University at Buffalo center dedicated to regenerating underdeveloped neighborhoods is joining the Community Health Equity Research Institute at UB.

Jacobs School of Medicine and Biomedical Sciences researchers have leveraged the power of digital pathology and computational modeling to develop a new approach to detecting and quantifying podocytes, which are specialized types of kidney cells that undergo damaging changes in both structure and function in the early stages of kidney disease.

Research in the laboratory of Zhen Yan, PhD, SUNY Distinguished Professor of physiology and biophysics, has revealed the biological mechanisms behind a key risk gene that plays a role in a number of brain diseases, including autism spectrum disorder (ASD).

A team of researchers in the Jacobs School of Medicine and Biomedical Sciences have developed a new, high-throughput screening method designed to quickly screen antiviral candidates against the SARS-CoV2 virus.